We are live on ! Find out more
SXTPW icon

60 Degrees Pharmaceuticals Warrant
SXTPW

8 hedge funds and large institutions have $56.3K invested in 60 Degrees Pharmaceuticals Warrant in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital inflows, than outflows

Capital inflows: $2.19K | Capital outflows: $1.31K

0% more funds holding

Funds holding: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

6.81% less ownership

Funds ownership: 13.6% → 6.79% (-6.8%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Virtu Financial
Virtu Financial
New York
+$1.13K
2
Citadel Advisors
Citadel Advisors
Florida
+$1.07K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.03K
2
Clear Street
Clear Street
New York
-$257
3
UBS Group
UBS Group
Switzerland
-$19

SXTPW Hedge Fund Activity: Q2 2024 in Review

8 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q2 2024, worth a combined $56.3K — down 9.2% from $62K a quarter earlier.

Fund positioning in SXTPW was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $1.13K. The largest seller was Sabby Management, cutting an estimated $1.03K.

  • 8 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $56.3K of 60 Degrees Pharmaceuticals Warrant stock for Q2 2024, down 9.2% quarter-over-quarter.
  • 1 fund opened new 60 Degrees Pharmaceuticals Warrant positions in Q2 2024 and 1 closed out, a net change of 0 holders.
  • The largest 60 Degrees Pharmaceuticals Warrant buyer in Q2 2024 was Virtu Financial, an estimated $1.13K added.
  • The largest 60 Degrees Pharmaceuticals Warrant seller in Q2 2024 was Sabby Management, an estimated $1.03K sold.

Based on aggregated 13F filings for Q2 2024.